2007/773/Euratom: Council Decision of 26 November 2007 on a one year extension of the supplementary research programme to be implemented by the Joint Research Centre for the European Atomic Energy Community
Date: 2007-11-26
Institutions: Council of the European Union
Subjects: France, Joint Research Centre, Member States' contribution, Netherlands, nuclear research, research programme

30.11.2007

EN

Official Journal of the European Union

L 312/29

(Acts adopted under the EC Treaty/Euratom Treaty whose publication is not obligatory)

II

DECISIONS

COUNCIL

COUNCIL DECISION

of 26 November 2007

on a one year extension of the supplementary research programme to be implemented by the Joint
Research Centre for the European Atomic Energy Community

(2007/773/Euratom)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty establishing the European Atomic
Energy Community, and in particular Article 7 thereof,

Having regard to the proposal from the Commission, submitted
after consultation of the Scientific and Technical Committee,

Having regard to the opinion of the Board of Governors of the
Joint Research Centre (JRC),

operator in February 2005. The supplementary research
programme should therefore be extended for a further
year to make use of the technical facilities available. The
extension should take effect retroactively, to cover the
ongoing activities of
the programme in the period
from 1 January 2007.

(5)

The financial contributions necessary for this extension
of
supplementary research programme will be
provided by the Netherlands and France,

the

Whereas:

HAS ADOPTED THIS DECISION:

(1)

(2)

The development of nuclear medicine within the
to the objective of
European Union contributes
It necessitates the
ensuring human health protection.
increased use of testing reactors for medical purposes.

On 19 February 2004, the Council adopted a Decision
concerning the adoption of a supplementary research
programme to be implemented by the Joint Research
Centre for the European Atomic Energy Community (1).
That programme was adopted for a period of three years,
until 1 January 2007.

(3) Within the framework of the European Research Area,
the supplementary research programme involving the
high flux reactor at Petten (the HFR)
the
principal means available in the Union to contribute to
the support and testing of medical diagnostic and ther-
apeutic methods,
to the development of materials
sciences and to problem-solving in the field of nuclear
energy.

is one of

(4)

The HFR is in operable condition until at least 2015, and
a new operating licence was granted to the reactor

(1) Council Decision 2004/185/Euratom of 19 February 2004 (OJ L 57,

25.2.2004, p. 25).

Article 1

The supplementary research programme on the operation of the
HFR (the Programme), the objectives of which are set out in
Annex I, shall be extended for a period of one year, with effect
from 1 January 2007.

Article 2

The financial contributions estimated for the execution of the
extension of the Programme shall amount to EUR 8 500 000.
The breakdown of the contributions is given in Annex II.

Article 3

The Commission shall be responsible for the implementation of
the Programme, and to this end, it shall call upon the services
of the JRC. The Board of Governors of the JRC shall be kept
informed about the implementation of the Programme.

Article 4

Before 15 June 2008,
European Parliament,
Social Committee a report on the implementation of
Decision.

the Commission shall submit to the
the Council and the Economic and
this

L 312/30

EN

Official Journal of the European Union

30.11.2007

This Decision shall enter into force on the day of its publication in the Official Journal of the European Union.

Article 5

It shall apply from 1 January 2007.

This Decision is addressed to the Member States.

Article 6

Done at Brussels, 26 November 2007.

For the Council
The President

J. SILVA

30.11.2007

EN

Official Journal of the European Union

L 312/31

ANNEX I

SCIENTIFIC AND TECHNICAL OBJECTIVES OF THE PROGRAMME

The objectives of the Programme are primarily:

1. The safe and reliable operation of the high flux reactor at Petten (the HFR); this activity involves the normal use of the
installation for more than 250 days a year and the management of the fuel cycle under the relevant safety and quality
controls.

2. The rational use of the HFR will be developed in a broad range of disciplines. The major research and development
themes involving the use of the HFR include: the improvement of safety of existing nuclear reactors; health, including
the development of medical
isotopes to answer the questions of medical research, and the testing of medical
therapeutic techniques; fusion; fundamental research and training; and, waste management, including the possibility
of developing nuclear fuels through the elimination of weapons-grade plutonium.

ANNEX II

BREAKDOWN OF THE CONTRIBUTIONS REFERRED TO IN ARTICLE 2

The contributions to the Programme will come from the Netherlands and France.

The breakdown of these contributions is as follows:

The Netherlands: EUR 8 200 000

France:

EUR 300 000

Total:

EUR 8 500 000